Autologous regulatory T cells for the treatment of type 1 diabetes. - Wikidata - awgldk - TriplyDB

Autologous regulatory T cells for the treatment of type 1 diabetes.

Autologous regulatory T cells for the treatment of type 1 diabetes.

http://www.wikidata.org/entity/Q38030480

about

Toward beta cell replacement for diabetes Restoring the balance: immunotherapeutic combinations for autoimmune disease Expansion of regulatory GITR+CD25 low/-CD4+ T cells in systemic lupus erythematosus patients.The changing landscape of type 1 diabetes: recent developments and future frontiers.It's time to bring dendritic cell therapy to type 1 diabetes.Expansion of Human Tregs from Cryopreserved Umbilical Cord Blood for GMP-Compliant Autologous Adoptive Cell Transfer Therapy.Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver.Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2.Patients with systemic lupus erythematosus and secondary antiphospholipid syndrome have decreased numbers of circulating CD4⁺CD25⁺Foxp3⁺ Treg and CD3⁻CD19⁺ B cells.Lower proportions of CD4+CD25(high) and CD4+FoxP3, but not CD4+CD25+CD127(low) FoxP3+ T cell levels in children with autoimmune thyroid diseases.Decreased levels of circulating CD4+CD25+Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome.

P2860

Q28083650-726B0ADE-0549-4A49-82A0-0A936041539F Q33555986-723F4DD9-7593-4CB3-87CB-7EDA9E61D3C5 Q34401977-9DA09CDE-78A4-4AD3-82DF-93022B199EA5 Q34891279-17253717-4EDE-434E-9BBB-BF4B49AFBEDC Q37670174-7E4398CF-7DF2-48D7-A67E-9D6786D31907 Q37717910-B2781033-5D38-4279-8DF6-3D89A1553E83 Q38490479-719BE131-E5C6-45DE-8CF6-007149D64B59 Q39665315-5409F964-9CEB-4806-BAF6-DFDD2C0A7AFE Q41920666-47B3DB21-F128-4777-915F-89608264E004 Q43540286-8DC6E0CA-A773-4203-9F85-61241805A984 Q43698661-BBB7B345-F9A5-45EF-B9D3-A8B833F2B0CA

P2860

Autologous regulatory T cells for the treatment of type 1 diabetes.

http://www.wikidata.org/entity/Q38030480

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Autologous regulatory T cells for the treatment of type 1 diabetes.

@en

type

label

Autologous regulatory T cells for the treatment of type 1 diabetes.

@en

prefLabel

Autologous regulatory T cells for the treatment of type 1 diabetes.

@en

P1433

Q38030480-64340BB0-96C2-444E-934B-EA3D7E91D071

P1476

Q38030480-721F466A-219C-4B78-825C-7A2B9576DB57

P2093

Q38030480-7DBA5A98-C755-43DD-B599-053B94CCB710

Q38030480-80F0841A-8AFE-4F50-A9AA-01FE0F17E5A2

Q38030480-82E1C80D-47B3-442A-B4DE-ACC2A6C48F1E

P2860

Q38030480-08A1F544-EF67-447A-910D-8F0549626FA7

Q38030480-0B502116-C039-4848-9184-40B0493E6432

Q38030480-0D72F694-866A-4789-9362-9C221B2EB500

Q38030480-10AFF117-2F11-4C0B-A378-DAEE2AE36F39

Q38030480-19597DE3-C1BC-41F4-A28F-5995A472B886

Q38030480-20982674-8EF7-41F0-9E61-1E3EFD3D5BD2

Q38030480-20EDFC00-B82C-47B3-8FBF-30271F10F809

Q38030480-2303307A-6895-492A-910D-33B9B3BAE46D

Q38030480-26D0DF9B-2167-450A-95E7-1B05C370A13C

Q38030480-2FB657FA-B50B-48E2-9618-21DDD2149A99

P2888

Q38030480-12B85AB1-4D51-426D-B33D-AE78C16149CA

P304

Q38030480-82599726-DC52-44F5-8BF9-73AD2EF4FE5E

P31

Q38030480-93E25093-8717-4F06-9330-7C441C4D6AD8

P356

Q38030480-0148AE38-D7FE-4A3C-AFC6-7440A62926E2

P433

Q38030480-13DC537F-BF56-43A4-8213-03F7103DBB87

P478

Q38030480-AE9C3276-9CE9-4151-A680-7A4650C5DEDB

P577

Q38030480-36B703AE-D321-4385-9C0A-E2B2C5AC516D

P6179

Q38030480-35697324-DF33-4E3F-AEC4-D3756ECB3C31

P698

Q38030480-B046E603-CBB1-44B5-8CDF-075079642168

P921

Q38030480-554F0975-BE47-4705-ADA3-F6D9B9AE550A

P356

S11892-012-0304-5

P1433

Current diabetes report

P1476

Autologous regulatory T cells for the treatment of type 1 diabetes.

@en

P2093

Daniel Perry

http://www.w3.org/2001/XMLSchema#string

James A Thompson

http://www.w3.org/2001/XMLSchema#string

Todd M Brusko

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-2 receptor signaling: at the interface between tolerance and immunity

Shared and distinct genetic variants in type 1 diabetes and celiac disease

Foxp3 occupancy and regulation of key target genes during T-cell stimulation

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant

P2888

s11892-012-0304-5

P304

623-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11892-012-0304-5

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042751223

http://www.w3.org/2001/XMLSchema#string

P698

22843491

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes